NEW YORK (GenomeWeb News) – Genomic services company SeqWright will use technologies from Roche subsidiaries 454 Life Sciences and NimbleGen to help drug developer Eli Lilly to identify genetic variants associated with psychiatric diseases, Roche said today.

Under the collaboration, SeqWright will use NimbleGen Sequence Capture technology to enrich around 40 megabases of the human genome, which will then be sequenced using 454 Life Sciences Genome Sequencer FLX System.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.